WATERTOWN, Mass., Jan. 26, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, ...
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is Cemsidomide, an orally ...
A look inside a Queens studio where Buddhas, sneakers and swans are carved with reverence and the knowledge that beauty, like ice, is fleeting. By Michaela Towfighi and Erin Schaff The Bautistas once ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results